BackToBasic; TNF alfa blocker treatment of chronic low-back pain with Modic changes, a randomized double blind multicenter placebo-controlled trial.
The AIM-study (Antibiotics In Modic changes); antibiotic treatment of chronic low-back pain with Modic changes, a randomised double blind multicenter placebo controlled trial.
The MI-NAV project: Can Motivational Interviewing facilitate Return-to-Work in sicklisted people with musculoskeletal disorders? A randomised trial within NAV.
The Lumbar Interbody Fusion vs. Multidisciplinary Rehabilitation (LIFEHAB) trial.
Epigenetic and molecular biomarkers in chronic low back pain and Modic changes. A casecontrol study.
Øie LR, Wergeland T, Salvesen Ø, Gravdahl GRB, Aschehoug I, Gulati S, Bj Rk MH, Lundqvist C, Alstadhaug KBR, Winsvold BS, Aamodt AH, Larsen IC, B E MG, Braschinsky M, Müller B, Vetvik KGT, Müller KI, Aaseth K, Khanevski AN, Øvrevik AB, Vegrim HM, Lindroos J, Eid K, Engstrand H, Bezgal Bet al.(2025) Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial Lancet Neurol, 24(10), 817-827 DOI 10.1016/S1474-4422(25)00269-8, PubMed 40975098
Toh ZA, Thambawita V, Grotle M, He HG, Pikkarainen M, Hey HWD, Solberg T, Ingebrigtsen T, Berg B(2025) Development of machine learning models for predicting patient-perceived benefit following lumbar disc herniation or spinal stenosis surgery Eur Spine J(in press) DOI 10.1007/s00586-025-09304-y, PubMed 40952504
Øiestad BE, Maas E, Aanesen F, Tingulstad A, Rysstad T, van Tulder M, Tveter AT, Hagen M, Berg RC, Foster NE, Wynne-Jones G, Sowden G, Bagøien G, Hagen R, Storheim K, Grotle M(2025) Effectiveness of two vocational interventions on sickness absence and costs for people with musculoskeletal disorders: 12 months results from the MI-NAV multi-arm randomized trial Scand J Work Environ Health(in press) DOI 10.5271/sjweh.4248, PubMed 40927942
